Terminated NCT00794963
This summary needs review. Please check the official study record and contact the research team for details.
In Glen Oaks Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 19 Years to 79 Years
Countries United States
Sponsor Northwell Health
Condition Schizophrenia Completed NCT00280813
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Baltimore Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 22 Years to 60 Years
Countries United States
Sponsor University of Maryland, Baltimore
Condition Schizophrenia Withdrawn NCT01567124
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Ballarat Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries Australia
Sponsor Baker Heart and Diabetes Institute
Condition Schizophrenia Completed ISRCTN68824876
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including London Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United Kingdom
Sponsor Imperial College London
Condition Schizophrenia Completed NCT00728195
This study is completed in Bulgaria, in Estonia, in Lithuania, .... It is testing 3 Fixed Doses of JNJ-37822681 for schizophrenia.
Multiple locations, including Burgas Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries Bulgaria, Estonia, Lithuania, ...
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT01009047
This study is completed in the United States, in India, in Romania, .... It is testing Extended-Release (ER) Paliperidone for schizophrenia.
Multiple locations, including Dothan Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 12 Years to 17 Years
Countries United States, India, Romania, ...
Sponsor Janssen Research & Development, LLC
Condition Schizophrenia Completed NCT00524043
This study is completed in the United States, in India, and in Taiwan. It is testing One Dosage of Paliperidone Extended Release (ER) for schizophrenia.
Multiple locations, including Cerritos Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States, India, Taiwan
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT00566631
This study is completed in France, in Croatia, in Germany, .... It is testing Paliperidone Extended-Release (ER) Tablets for schizophrenia.
Multiple locations, including Zagreb Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries France, Croatia, Germany, ...
Sponsor Janssen-Cilag International NV
Condition Schizophrenia Completed NCT01299389
This study is completed in Japan, in South Korea, and in Taiwan. It is testing paliperidone Palmitate for schizophrenia.
Multiple locations, including Fujioka Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 20 Years
Countries Japan, South Korea, Taiwan
Sponsor Janssen Pharmaceutical K.K.
Condition Schizophrenia Completed NCT01662310
This study is completed in China. It is testing paliperidone for schizophrenia.
Multiple locations, including Baoding Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries China
Sponsor Janssen Research & Development, LLC
Condition Schizophrenia Completed NCT03865186
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 60 Years
Countries
Sponsor Kırıkkale University
Condition Schizophrenia Terminated NCT00412620
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Anaheim Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Argentina, Mexico
Sponsor Abbott
Condition Schizophrenia